216 related articles for article (PubMed ID: 32179514)
21. The two isoenzymes for yeast NAD+-dependent glycerol 3-phosphate dehydrogenase encoded by GPD1 and GPD2 have distinct roles in osmoadaptation and redox regulation.
Ansell R; Granath K; Hohmann S; Thevelein JM; Adler L
EMBO J; 1997 May; 16(9):2179-87. PubMed ID: 9171333
[TBL] [Abstract][Full Text] [Related]
22. Glycerol 3-phosphate dehydrogenase 1 deficiency enhances exercise capacity due to increased lipid oxidation during strenuous exercise.
Sato T; Morita A; Mori N; Miura S
Biochem Biophys Res Commun; 2015 Feb; 457(4):653-8. PubMed ID: 25603051
[TBL] [Abstract][Full Text] [Related]
23. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
24. Anaerobic and aerobic batch cultivations of Saccharomyces cerevisiae mutants impaired in glycerol synthesis.
Nissen TL; Hamann CW; Kielland-Brandt MC; Nielsen J; Villadsen J
Yeast; 2000 Mar; 16(5):463-74. PubMed ID: 10705374
[TBL] [Abstract][Full Text] [Related]
25. Metformin's Therapeutic Efficacy in the Treatment of Diabetes Does Not Involve Inhibition of Mitochondrial Glycerol Phosphate Dehydrogenase.
MacDonald MJ; Ansari IH; Longacre MJ; Stoker SW
Diabetes; 2021 Jul; 70(7):1575-1580. PubMed ID: 33849997
[TBL] [Abstract][Full Text] [Related]
26. The importance of the glycerol 3-phosphate shuttle during aerobic growth of Saccharomyces cerevisiae.
Larsson C; Påhlman IL; Ansell R; Rigoulet M; Adler L; Gustafsson L
Yeast; 1998 Mar; 14(4):347-57. PubMed ID: 9559543
[TBL] [Abstract][Full Text] [Related]
27. GlcA-mediated glycerol-3-phosphate synthesis contributes to the oxidation resistance of Aspergillus fumigatus via decreasing the cellular ROS.
Zhang C; Gu H; Ren Y; Lu L
Fungal Genet Biol; 2021 Apr; 149():103531. PubMed ID: 33581364
[TBL] [Abstract][Full Text] [Related]
28. Engineering of Saccharomyces cerevisiae for the production of L-glycerol 3-phosphate.
Nguyen HT; Dieterich A; Athenstaedt K; Truong NH; Stahl U; Nevoigt E
Metab Eng; 2004 Apr; 6(2):155-63. PubMed ID: 15113568
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
30. Genetic engineering of brewing yeast to reduce the content of ethanol in beer.
Nevoigt E; Pilger R; Mast-Gerlach E; Schmidt U; Freihammer S; Eschenbrenner M; Garbe L; Stahl U
FEMS Yeast Res; 2002 May; 2(2):225-32. PubMed ID: 12702310
[TBL] [Abstract][Full Text] [Related]
31. Genistein and metformin regulate glycerol kinase and the enzymes of glycerol 3-phosphate shuttle in a differential manner in myocytes, hepatocytes and adipocytes.
Syngkli S; Singh SK; Rani RM; Das B
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132296. PubMed ID: 38740159
[TBL] [Abstract][Full Text] [Related]
32. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
[TBL] [Abstract][Full Text] [Related]
33. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
34. Adaptation of the glycerol-3-phosphate dehydrogenase Gpd1 to high salinities in the extremely halotolerant Hortaea werneckii and halophilic Wallemia ichthyophaga.
Lenassi M; Zajc J; Gostinčar C; Gorjan A; Gunde-Cimerman N; Plemenitaš A
Fungal Biol; 2011 Oct; 115(10):959-70. PubMed ID: 21944208
[TBL] [Abstract][Full Text] [Related]
35. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
Mogavero A; Maiorana MV; Zanutto S; Varinelli L; Bozzi F; Belfiore A; Volpi CC; Gloghini A; Pierotti MA; Gariboldi M
Sci Rep; 2017 Nov; 7(1):15992. PubMed ID: 29167573
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production.
Pecinova A; Drahota Z; Kovalcikova J; Kovarova N; Pecina P; Alan L; Zima M; Houstek J; Mracek T
Oxid Med Cell Longev; 2017; 2017():7038603. PubMed ID: 28874953
[TBL] [Abstract][Full Text] [Related]
37. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
38. Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell MB
Cell Biochem Biophys; 2017 Dec; 75(3-4):311-317. PubMed ID: 28429253
[TBL] [Abstract][Full Text] [Related]
39. ROS generation and multiple forms of mammalian mitochondrial glycerol-3-phosphate dehydrogenase.
Mráček T; Holzerová E; Drahota Z; Kovářová N; Vrbacký M; Ješina P; Houštěk J
Biochim Biophys Acta; 2014 Jan; 1837(1):98-111. PubMed ID: 23999537
[TBL] [Abstract][Full Text] [Related]
40. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.
Buzzai M; Jones RG; Amaravadi RK; Lum JJ; DeBerardinis RJ; Zhao F; Viollet B; Thompson CB
Cancer Res; 2007 Jul; 67(14):6745-52. PubMed ID: 17638885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
